Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 687,131 |
|
|||||
| News | - | ||||||
| Day High | 2.55 | Low High |
|||||
| Day Low | 2.33 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lyell Immunopharma Inc | LYEL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.03 | 1.24% | 2.44 | 18:21:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.33 | 2.33 | 2.55 | 2.44 | 2.41 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,656 | 687,131 | $ 2.48 | $ 1,704,478 | - | 1.32 - 3.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:52:00 | 10 | $ 2.39 | USD |
Lyell Immunopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 619.99M | 254.10M | - | 2.92M | -234.63M | -0.92 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lyell Immunopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LYEL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.36 | 2.55 | 2.15 | 2.35 | 1,052,837 | 0.08 | 3.39% |
| 1 Month | 1.93 | 3.145 | 1.90 | 2.41 | 1,001,347 | 0.51 | 26.42% |
| 3 Months | 2.06 | 3.2556 | 1.69 | 2.27 | 931,011 | 0.38 | 18.45% |
| 6 Months | 1.52 | 3.2556 | 1.50 | 2.09 | 1,129,479 | 0.92 | 60.53% |
| 1 Year | 2.28 | 3.97 | 1.32 | 2.31 | 1,022,381 | 0.16 | 7.02% |
| 3 Years | 18.75 | 19.84 | 1.32 | 4.82 | 942,220 | -16.31 | -86.99% |
| 5 Years | 18.75 | 19.84 | 1.32 | 4.82 | 942,220 | -16.31 | -86.99% |
Lyell Immunopharma Description
| Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors). |
